IGWM
VKTX icon

ICA Group Wealth Management’s Viking Therapeutics VKTX Stock Holding History

ICA Group Wealth Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$13K Sell
245
-35
-13% -$2.29K 0.01% 437
2024
Q1 		$23K Buy
280
+230
+460% +$10.2K ﹤0.01% 728
2023
Q4 		$931 Buy
+50
New +$654 ﹤0.01% 1236
2023
Q3 		– Sell
-50
Closed -$811 – 1197
2023
Q2 		$811 Hold
50
– – ﹤0.01% 1216
2023
Q1 		$833 Buy
+50
New +$516 ﹤0.01% 1159

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ICA Group Wealth Management's VKTX Position: Q2 2024 in Review

ICA Group Wealth Management reduced its Viking Therapeutics (VKTX) stake by 13% in Q2 2024, selling an estimated $2.29K and leaving 245 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #437.

ICA Group Wealth Management first reported a position in VKTX in Q1 2023 and has held it in 5 quarters since. The position peaked at $23K in Q1 2024. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

  • ICA Group Wealth Management held 245 shares of Viking Therapeutics worth $13K as of Q2 2024.
  • ICA Group Wealth Management sold 35 Viking Therapeutics shares in Q2 2024, an estimated $2.29K.
  • Viking Therapeutics made up 0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #437 holding.
  • ICA Group Wealth Management first reported a position in Viking Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • ICA Group Wealth Management's Viking Therapeutics position peaked at $23K in Q1 2024.
  • 387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.